VREX
Varex Imaging Corp
Company overview
- Market capitalization
- $777.17M
- Employees
- 2,450
- Latest publication
- 2026-09-29
About Varex Imaging Corp
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
Financial statements
Income Quarterly
| Metric | Q3 20262026-07-03 · USD | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 210,500,000USD | 216,000,000USD | 209,600,000USD | 228,900,000USD | 212,900,000USD | 199,800,000USD | 205,700,000USD | 209,100,000USD |
| Cost Of Revenue | 133,800,000USD | 143,400,000USD | 139,800,000USD | 151,100,000USD | 136,200,000USD | 131,300,000USD | 138,600,000USD | 142,200,000USD |
| Gross Profit | 76,700,000USD | 72,600,000USD | 69,800,000USD | 77,800,000USD | 76,700,000USD | 68,500,000USD | 67,100,000USD | 66,900,000USD |
| Research Development | 23,300,000USD | 22,200,000USD | 21,700,000USD | 24,200,000USD | 22,000,000USD | 23,500,000USD | 21,900,000USD | 22,000,000USD |
| Selling General Administrative | 30,600,000USD | 36,000,000USD | 32,700,000USD | 34,000,000USD | 32,600,000USD | 33,800,000USD | 34,300,000USD | 35,600,000USD |
| Total Operating Expenses | 53,900,000USD | 58,200,000USD | 54,400,000USD | 58,200,000USD | 54,600,000USD | 57,300,000USD | 56,200,000USD | 57,600,000USD |
| Operating Income | 22,800,000USD | 14,400,000USD | 15,400,000USD | 19,600,000USD | 22,100,000USD | 11,200,000USD | 10,900,000USD | 9,300,000USD |
| Total Other Income Expense Net | -6,600,000USD | -20,800,000USD | -11,600,000USD | -5,500,000USD | -11,300,000USD | -8,700,000USD | -8,400,000USD | -8,500,000USD |
| Interest Income | 900,000USD | 400,000USD | 600,000USD | 1,000,000USD | 2,900,000USD | 2,100,000USD | 1,800,000USD | 1,800,000USD |
| Interest Expense | 5,800,000USD | 17,300,000USD | 7,900,000USD | 7,900,000USD | 10,400,000USD | 8,199,999USD | 7,800,000USD | 7,600,000USD |
| Income Before Tax | 16,200,000USD | -6,400,000USD | 3,800,000USD | 14,100,000USD | 10,800,000USD | 2,500,000USD | 2,500,000USD | 800,000USD |
| Income Tax Expense | 300,000USD | 1,600,000USD | 1,400,000USD | 1,900,000USD | 3,700,000USD | 2,600,000USD | 52,400,000USD | -700,000USD |
| Net Income | 15,900,000USD | -8,100,000USD | 2,300,000USD | 12,200,000USD | 6,900,000USD | -300,000USD | -50,000,000USD | 1,400,000USD |
| Minority Interest | 200,000USD | -100,000USD | -100,000USD | 0USD | -200,000USD | -200,000USD | -100,000USD | -100,000USD |
| Net Income Applicable To Common Shares | 15,700,000USD | — | — | — | — | — | — | — |
| Net Interest Income | — | -7,400,000USD | -7,300,000USD | -6,900,000USD | -7,300,000USD | -5,900,000USD | -5,800,000USD | -5,600,000USD |
| Tax Provision | — | 1,600,000USD | 1,400,000USD | 1,900,000USD | 3,700,000USD | 2,600,000USD | 52,400,000USD | -700,000USD |
| Net Income From Continuing Ops | — | -8,000,000USD | 2,400,000USD | 12,200,000USD | 7,100,000USD | -100,000USD | -49,900,000USD | 1,500,000USD |
| Ebit | — | 10,900,000USD | 11,700,000USD | 22,000,000USD | 21,200,000USD | 10,700,000USD | 10,300,000USD | 6,500,000USD |
| Ebitda | — | 17,700,000USD | 18,500,000USD | 28,700,000USD | 27,800,000USD | 17,800,000USD | 16,900,000USD | 13,500,000USD |
| Depreciation And Amortization | — | 6,800,000USD | 6,800,000USD | 6,700,000USD | 6,600,000USD | 7,100,000USD | 6,600,000USD | 7,000,000USD |
| Reconciled Depreciation | — | 6,800,000USD | 6,800,000USD | 6,700,000USD | 6,600,000USD | 7,100,000USD | 6,600,000USD | 7,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD | FY 20172017-09-30 · USD | FY 20162016-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 811,000,000USD | 893,400,000USD | 859,400,000USD | 818,100,000USD | 780,600,000USD | 773,400,000USD | 698,100,000USD | 620,100,000USD |
| Cost Of Revenue | 554,100,000USD | 603,100,000USD | 575,900,000USD | 546,600,000USD | 523,900,000USD | 519,500,000USD | 444,600,000USD | 371,700,000USD |
| Gross Profit | 256,900,000USD | 290,300,000USD | 283,500,000USD | 271,500,000USD | 256,700,000USD | 253,900,000USD | 253,500,000USD | 248,400,000USD |
| Research Development | 87,000,000USD | 84,800,000USD | 77,000,000USD | 71,900,000USD | 78,100,000USD | 83,000,000USD | 67,300,000USD | 53,500,000USD |
| Selling General Administrative | 137,800,000USD | 128,400,000USD | 118,300,000USD | 125,500,000USD | 128,100,000USD | 126,400,000USD | 102,500,000USD | 85,800,000USD |
| Total Operating Expenses | 224,800,000USD | 213,200,000USD | 195,300,000USD | 197,400,000USD | 206,200,000USD | 209,400,000USD | 169,800,000USD | 139,300,000USD |
| Operating Income | 32,100,000USD | 77,100,000USD | 88,200,000USD | 74,100,000USD | 8,200,000USD | 44,500,000USD | 83,700,000USD | 109,100,000USD |
| Interest Income | 7,300,000USD | 3,700,000USD | 400,000USD | 100,000USD | 100,000USD | 200,000USD | 200,000USD | 300,000USD |
| Interest Expense | 31,100,000USD | 29,300,000USD | 41,000,000USD | 43,400,000USD | 21,100,000USD | 21,700,000USD | 12,300,000USD | 1,900,000USD |
| Net Interest Income | -22,900,000USD | -25,600,000USD | -39,400,000USD | -42,000,000USD | -21,000,000USD | -21,500,000USD | -12,100,000USD | -1,600,000USD |
| Income Before Tax | 5,000,000USD | 31,300,000USD | 44,500,000USD | 28,600,000USD | 21,500,000USD | 25,700,000USD | 74,800,000USD | 105,000,000USD |
| Income Tax Expense | 52,200,000USD | -16,600,000USD | 13,700,000USD | 10,700,000USD | 5,700,000USD | -2,600,000USD | 22,800,000USD | 36,000,000USD |
| Tax Provision | 52,200,000USD | -17,400,000USD | 13,700,000USD | 10,700,000USD | 5,700,000USD | -2,600,000USD | 22,800,000USD | 36,000,000USD |
| Net Income | -47,700,000USD | 47,400,000USD | 30,300,000USD | 17,400,000USD | 15,500,000USD | 27,500,000USD | 51,600,000USD | 68,500,000USD |
| Net Income From Continuing Ops | -47,200,000USD | 48,700,000USD | 30,800,000USD | 17,900,000USD | 15,800,000USD | 28,300,000USD | 52,000,000USD | 69,000,000USD |
| Ebit | 31,800,000USD | 61,500,000USD | 80,900,000USD | 67,200,000USD | 44,700,000USD | 47,500,000USD | 83,700,000USD | 106,900,000USD |
| Ebitda | 62,900,000USD | 94,700,000USD | 114,500,000USD | 104,500,000USD | 83,900,000USD | 89,700,000USD | 111,100,000USD | 122,200,000USD |
| Depreciation And Amortization | 31,100,000USD | 33,200,000USD | 33,600,000USD | 37,300,000USD | 39,200,000USD | 42,200,000USD | 27,400,000USD | 15,300,000USD |
| Reconciled Depreciation | 31,100,000USD | 32,500,000USD | 33,600,000USD | 37,300,000USD | 39,200,000USD | 42,200,000USD | 27,400,000USD | — |
| Total Other Income Expense Net | -27,100,000USD | -45,800,000USD | -43,700,000USD | -45,500,000USD | -24,200,000USD | -18,800,000USD | -8,900,000USD | -4,100,000USD |
| Minority Interest | -500,000USD | -500,000USD | -500,000USD | -500,000USD | 13,800,000USD | 13,200,000USD | 11,200,000USD | 10,300,000USD |
| Non Operating Income Net Other | — | — | -3,900,000USD | -3,400,000USD | -3,100,000USD | 2,900,000USD | 3,400,000USD | — |
| Net Income Applicable To Common Shares | — | — | 30,300,000USD | 17,400,000USD | 15,500,000USD | 27,500,000USD | 51,600,000USD | 68,500,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q3 20262026-07-03 · USD | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,100,000,000USD | 1,089,400,000USD | 1,098,000,000USD | 1,107,400,000USD | 1,073,400,000USD | 1,357,600,000USD | 1,332,200,000USD | 1,217,000,000USD |
| Cash And Equivalents | 99,200,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 99,200,000USD | 88,300,000USD | 125,600,000USD | 155,100,000USD | 152,600,000USD | 223,000,000USD | 212,600,000USD | 200,500,000USD |
| Short Term Investments | 0USD | 3,000,000USD | 6,100,000USD | 10,100,000USD | 16,200,000USD | 17,900,000USD | 36,600,000USD | 31,800,000USD |
| Total Current Assets | 633,100,000USD | 625,600,000USD | 633,600,000USD | 641,800,000USD | 619,500,000USD | 683,800,000USD | 656,900,000USD | 649,900,000USD |
| Other Current Assets | 42,100,000USD | 41,700,000USD | 33,500,000USD | 29,900,000USD | 30,400,000USD | 29,600,000USD | 26,300,000USD | 26,900,000USD |
| Other Non Current Assets | 37,700,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 589,500,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 187,400,000USD | 195,300,000USD | 163,000,000USD | 187,200,000USD | 176,700,000USD | 168,800,000USD | 150,500,000USD | 195,900,000USD |
| Other Current Liabilities | 72,600,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 46,700,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 496,600,000USD | 474,200,000USD | 476,900,000USD | 472,600,000USD | 455,300,000USD | 549,700,000USD | 540,200,000USD | 535,100,000USD |
| Total Equity Including Noncontrolling Interest | 510,500,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 18,200,000USD | 18,600,000USD | 1,400,000USD | 1,500,000USD | 1,500,000USD | 1,400,000USD | 1,400,000USD | 46,300,000USD |
| Long Term Debt | 328,900,000USD | 329,000,000USD | 366,200,000USD | 366,000,000USD | 366,000,000USD | 565,800,000USD | 565,600,000USD | 397,100,000USD |
| Deferred Revenue | 8,600,000USD | — | — | — | — | — | — | — |
| Net Receivables | 144,700,000USD | 148,900,000USD | 146,500,000USD | 157,400,000USD | 137,800,000USD | 146,500,000USD | 138,100,000USD | 157,700,000USD |
| Inventory | 347,100,000USD | 346,700,000USD | 328,000,000USD | 299,400,000USD | 298,700,000USD | 284,700,000USD | 279,900,000USD | 264,800,000USD |
| Property Plant Equipment Net | 197,000,000USD | 192,400,000USD | 189,300,000USD | 187,200,000USD | 176,700,000USD | 177,600,000USD | 178,200,000USD | 181,700,000USD |
| Goodwill | 197,600,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 12,400,000USD | 13,200,000USD | 14,700,000USD | 14,000,000USD | 15,000,000USD | 15,300,000USD | 14,200,000USD | 16,100,000USD |
| Accounts Payable | 83,500,000USD | 96,400,000USD | 78,900,000USD | 69,900,000USD | 70,700,000USD | 70,800,000USD | 65,600,000USD | 59,100,000USD |
| Short Term Debt | 4,500,000USD | 23,700,000USD | 6,000,000USD | 6,300,000USD | 5,800,000USD | 5,700,000USD | 8,800,000USD | 50,300,000USD |
| Retained Earnings | 4,000,000USD | -11,700,000USD | -3,600,000USD | -5,900,000USD | -18,100,000USD | 77,000,000USD | 70,100,000USD | 70,400,000USD |
| Accumulated Other Comprehensive Income | -2,900,000USD | -5,600,000USD | -5,500,000USD | -5,200,000USD | -5,400,000USD | -2,400,000USD | -300,000USD | -2,900,000USD |
| Total Liab | — | 601,300,000USD | 607,200,000USD | 620,800,000USD | 603,900,000USD | 793,700,000USD | 778,000,000USD | 667,800,000USD |
| Other Current Liab | — | 60,700,000USD | 65,700,000USD | 98,000,000USD | 85,600,000USD | 82,600,000USD | 66,700,000USD | 70,500,000USD |
| Common Stock | — | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD |
| Capital Stock | — | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD |
| Good Will | — | 197,800,000USD | 198,400,000USD | 198,400,000USD | 198,500,000USD | 290,300,000USD | 287,200,000USD | 291,000,000USD |
| Cash | — | 85,300,000USD | 119,500,000USD | 145,000,000USD | 136,400,000USD | 205,100,000USD | 176,000,000USD | 168,700,000USD |
| Current Deferred Revenue | — | 14,500,000USD | 12,400,000USD | 13,000,000USD | 14,600,000USD | 9,700,000USD | 9,400,000USD | 7,900,000USD |
| Net Debt | — | 295,700,000USD | 276,000,000USD | 256,900,000USD | 260,500,000USD | 391,700,000USD | 425,600,000USD | 301,700,000USD |
| Short Long Term Debt Total | — | 381,000,000USD | 395,500,000USD | 401,900,000USD | 396,900,000USD | 596,800,000USD | 601,600,000USD | 470,400,000USD |
| Long Term Investments | — | 20,000,000USD | 21,300,000USD | 24,500,000USD | 24,600,000USD | 23,200,000USD | 25,200,000USD | 26,800,000USD |
| Property Plant Equipment Gross | — | 192,400,000USD | 189,300,000USD | 458,200,000USD | 176,700,000USD | 177,600,000USD | 178,200,000USD | 433,900,000USD |
| Common Stock Shares Outstanding | — | 41,900,000shares | 42,300,000shares | 41,800,000shares | 41,500,000shares | 51,200,000shares | 41,100,000shares | 40,800,000shares |
| Non Current Assets Total | — | 463,800,000USD | 464,400,000USD | 465,600,000USD | 453,900,000USD | 673,800,000USD | 675,300,000USD | 567,100,000USD |
| Non Current Liabilities Total | — | 405,999,999USD | 444,200,000USD | 433,599,999USD | 427,200,000USD | 624,900,000USD | 627,500,000USD | 471,900,000USD |
| Non Current Liabilities Other | — | 48,200,000USD | 49,200,000USD | 29,600,000USD | 39,200,000USD | 39,500,000USD | 40,500,000USD | 31,900,000USD |
| Non Currrent Assets Other | — | 35,100,000USD | 37,800,000USD | 36,500,000USD | 34,000,000USD | 37,300,000USD | 167,400,000USD | 46,800,000USD |
| Net Working Capital | — | 430,300,000USD | 470,600,000USD | 454,600,000USD | 442,800,000USD | 515,000,000USD | 506,400,000USD | 454,000,000USD |
| Unclassified Non Current Assets | — | 5,300,000USD | — | 5,000,000USD | 5,100,000USD | 130,100,000USD | — | — |
| Unclassified Current Liabilities | — | -18,600,000USD | — | — | — | — | — | -38,200,000USD |
| Unclassified Non Current Liabilities | — | 28,799,999USD | 28,800,000USD | 37,999,999USD | 22,000,000USD | 19,600,000USD | 21,400,000USD | 42,900,000USD |
| Unclassified Equity | — | 490,700,000USD | 485,200,000USD | 482,900,000USD | 478,000,000USD | 474,300,000USD | 469,600,000USD | 466,800,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,107,400,000USD | 1,217,000,000USD | 1,249,600,000USD | 1,184,400,000USD | 1,147,500,000USD | 1,139,500,000USD | 1,040,800,000USD | 988,500,000USD |
| Intangible Assets | 14,000,000USD | 16,100,000USD | 22,400,000USD | 33,600,000USD | 50,700,000USD | 67,500,000USD | 86,300,000USD | 73,800,000USD |
| Other Current Assets | 29,900,000USD | 26,900,000USD | 22,600,000USD | 44,000,000USD | 29,500,000USD | 25,700,000USD | 19,100,000USD | 32,000,000USD |
| Total Liab | 620,800,000USD | 667,800,000USD | 668,600,000USD | 637,700,000USD | 651,000,000USD | 673,700,000USD | 581,000,000USD | 549,100,000USD |
| Total Stockholder Equity | 472,600,000USD | 535,100,000USD | 567,700,000USD | 533,400,000USD | 483,300,000USD | 451,700,000USD | 446,000,000USD | 426,200,000USD |
| Other Current Liab | 98,000,000USD | 70,500,000USD | 62,000,000USD | 63,100,000USD | 81,500,000USD | 64,700,000USD | 65,000,000USD | 46,100,000USD |
| Common Stock | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD |
| Capital Stock | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD | 400,000USD |
| Retained Earnings | -5,900,000USD | 70,400,000USD | 118,100,000USD | 63,800,000USD | 33,500,000USD | 16,900,000USD | 75,500,000USD | 62,400,000USD |
| Good Will | 198,400,000USD | 291,000,000USD | 288,500,000USD | 284,500,000USD | 292,200,000USD | 293,100,000USD | 290,800,000USD | 243,600,000USD |
| Cash | 145,000,000USD | 168,700,000USD | 152,600,000USD | 89,400,000USD | 144,600,000USD | 100,600,000USD | 29,900,000USD | 51,900,000USD |
| Cash And Short Term Investments | 155,100,000USD | 200,500,000USD | 193,900,000USD | 89,400,000USD | 144,600,000USD | 100,600,000USD | 29,900,000USD | 51,900,000USD |
| Total Current Assets | 641,800,000USD | 649,900,000USD | 658,300,000USD | 609,900,000USD | 554,200,000USD | 522,000,000USD | 440,300,000USD | 458,100,000USD |
| Total Current Liabilities | 187,200,000USD | 195,900,000USD | 162,800,000USD | 173,100,000USD | 166,600,000USD | 160,600,000USD | 175,100,000USD | 152,600,000USD |
| Current Deferred Revenue | 13,000,000USD | 7,900,000USD | 17,400,000USD | 14,200,000USD | 9,100,000USD | 8,600,000USD | 10,500,000USD | 13,200,000USD |
| Net Debt | 256,900,000USD | 301,700,000USD | 317,200,000USD | 347,000,000USD | 314,800,000USD | 383,900,000USD | 365,200,000USD | 337,900,000USD |
| Short Term Debt | 6,300,000USD | 50,300,000USD | 5,400,000USD | 6,300,000USD | 9,200,000USD | 8,800,000USD | 30,700,000USD | 25,000,000USD |
| Short Long Term Debt | 1,500,000USD | 46,300,000USD | 1,500,000USD | 2,100,000USD | 2,800,000USD | 2,500,000USD | 30,700,000USD | 25,000,000USD |
| Short Long Term Debt Total | 401,900,000USD | 470,400,000USD | 469,800,000USD | 436,400,000USD | 459,400,000USD | 484,500,000USD | 395,100,000USD | 389,800,000USD |
| Long Term Debt | 366,000,000USD | 397,100,000USD | 441,100,000USD | 412,300,000USD | 431,700,000USD | 452,800,000USD | 364,400,000USD | 364,800,000USD |
| Long Term Investments | 24,500,000USD | 26,800,000USD | 29,000,000USD | 46,400,000USD | 49,300,000USD | 51,300,000USD | 53,600,000USD | 51,000,000USD |
| Short Term Investments | 10,100,000USD | 31,800,000USD | 41,300,000USD | 14,500,000USD | — | 51,000,000USD | — | 2,200,000USD |
| Net Receivables | 157,400,000USD | 157,700,000USD | 164,300,000USD | 173,300,000USD | 155,300,000USD | 123,800,000USD | 141,000,000USD | 154,000,000USD |
| Inventory | 299,400,000USD | 264,800,000USD | 277,500,000USD | 303,200,000USD | 224,800,000USD | 271,900,000USD | 250,300,000USD | 235,100,000USD |
| Accounts Payable | 69,900,000USD | 59,100,000USD | 64,700,000USD | 78,200,000USD | 58,800,000USD | 72,900,000USD | 58,200,000USD | 66,300,000USD |
| Property Plant Equipment Net | 187,200,000USD | 181,700,000USD | 172,600,000USD | 164,500,000USD | 164,500,000USD | 172,900,000USD | 142,300,000USD | 144,900,000USD |
| Property Plant Equipment Gross | 458,200,000USD | 433,900,000USD | 172,600,000USD | 164,500,000USD | 164,500,000USD | 172,900,000USD | 142,300,000USD | 144,900,000USD |
| Accumulated Other Comprehensive Income | -5,200,000USD | -2,900,000USD | -1,200,000USD | 100,000USD | 0USD | 800,000USD | -1,700,000USD | 5,800,000USD |
| Common Stock Shares Outstanding | 41,400,000shares | 40,800,000shares | 50,300,000shares | 41,600,000shares | 40,300,000shares | 38,800,000shares | 38,600,000shares | 38,400,000shares |
| Non Current Assets Total | 465,600,000USD | 567,100,000USD | 591,300,000USD | 574,500,000USD | 593,300,000USD | 617,500,000USD | 600,500,000USD | 530,400,000USD |
| Non Current Liabilities Total | 433,599,999USD | 471,900,000USD | 505,800,000USD | 464,600,000USD | 484,400,000USD | 513,100,000USD | 405,900,000USD | 396,500,000USD |
| Non Current Liabilities Other | 29,600,000USD | 31,900,000USD | 41,600,000USD | 33,800,000USD | 31,800,000USD | 24,500,000USD | 23,100,000USD | 1,700,000USD |
| Non Currrent Assets Other | 36,500,000USD | 46,800,000USD | 36,100,000USD | 43,200,000USD | 32,600,000USD | 32,200,000USD | 27,500,000USD | -6,100,000USD |
| Net Working Capital | 454,600,000USD | 454,000,000USD | 495,500,000USD | 436,800,000USD | 387,600,000USD | 361,400,000USD | 263,300,000USD | 306,100,000USD |
| Unclassified Non Current Assets | 5,000,000USD | — | 42,700,000USD | — | -28,700,000USD | -32,200,000USD | -27,500,000USD | 6,100,000USD |
| Unclassified Non Current Liabilities | 37,999,999USD | 42,900,000USD | 23,100,000USD | -16,300,000USD | -18,500,000USD | — | -30,000,000USD | -24,900,000USD |
| Unclassified Equity | 482,900,000USD | 466,800,000USD | 450,000,000USD | 468,700,000USD | 449,000,000USD | 433,200,000USD | 371,400,000USD | — |
| Unclassified Current Liabilities | — | -38,200,000USD | 11,800,000USD | 9,200,000USD | 5,200,000USD | 3,100,000USD | -20,000,000USD | -23,000,000USD |
| Deferred Long Term Liab | — | — | — | 500,000USD | 2,200,000USD | 2,300,000USD | 8,200,000USD | 23,200,000USD |
| Other Liab | — | — | — | 34,300,000USD | 37,200,000USD | 36,800,000USD | 40,200,000USD | 31,700,000USD |
| Other Assets | — | — | — | -13,200,000USD | 32,700,000USD | 32,700,000USD | 27,500,000USD | 11,000,000USD |
| Net Tangible Assets | — | — | — | 215,300,000USD | 91,100,000USD | 91,100,000USD | 67,800,000USD | 108,800,000USD |
| Unclassified Current Assets | — | — | — | -14,500,000USD | — | -51,000,000USD | — | -17,100,000USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 357,600,000USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q3 20262026-07-03 · USD |
|---|---|
| Depreciation | 20,600,000USD |
| Stock Based Compensation | 11,600,000USD |
| Other Non Cash Items | -12,000,000USD |
| Change To Account Receivables | 11,000,000USD |
| Change To Inventory | -53,400,000USD |
| Change To Liabilities | -7,800,000USD |
| Change In Working Capital | -36,800,000USD |
| Operating Cash Flow | 3,400,000USD |
| Capital Expenditures | -25,900,000USD |
| Net Investments | 10,100,000USD |
| Other Investing Activities | 1,300,000USD |
| Unclassified Investing Cash Flow | -2,600,000USD |
| Investing Cash Flow | -17,100,000USD |
| Net Debt Issuance | -300,000USD |
| Common Stock Issuance | 1,700,000USD |
| Net Common Stock Issuance | -1,500,000USD |
| Other Financing Activities | -800,000USD |
| Unclassified Financing Cash Flow | -31,200,000USD |
| Financing Cash Flow | -32,100,000USD |
| Effect Of Forex Changes On Cash | -200,000USD |
| Change In Cash | -46,000,000USD |
| End Cash Flow | 101,100,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -8,100,000USD | 2,300,000USD | 12,200,000USD | -89,100,000USD | 7,100,000USD | -100,000USD | -50,000,000USD | 1,400,000USD |
| Depreciation | 6,800,000USD | 6,800,000USD | 6,700,000USD | 6,800,000USD | 6,600,000USD | 7,100,000USD | 6,600,000USD | 7,000,000USD |
| Stock Based Compensation | 4,000,000USD | 3,800,000USD | 3,400,000USD | 3,700,000USD | 3,800,000USD | 4,100,000USD | 3,500,000USD | 3,900,000USD |
| Other Non Cash Items | 18,300,000USD | 5,400,000USD | -600,000USD | 93,200,000USD | 3,800,000USD | 4,900,000USD | 2,900,000USD | 3,800,000USD |
| Change To Account Receivables | -1,100,000USD | 8,900,000USD | -20,100,000USD | 8,600,000USD | -7,900,000USD | 19,500,000USD | -5,700,000USD | -600,000USD |
| Change To Inventory | -21,800,000USD | -30,100,000USD | -2,300,000USD | -16,500,000USD | -5,500,000USD | -15,600,000USD | 14,600,000USD | 3,800,000USD |
| Change In Working Capital | -18,400,000USD | -35,000,000USD | -16,500,000USD | -3,500,000USD | -4,800,000USD | -6,600,000USD | 11,500,000USD | -400,000USD |
| Total Cash From Operating Activities | -1,500,000USD | -16,100,000USD | 7,900,000USD | 7,700,000USD | 16,600,000USD | 9,500,000USD | 25,900,000USD | 8,000,000USD |
| Capital Expenditures | -6,200,000USD | -10,700,000USD | -5,600,000USD | -6,300,000USD | -6,800,000USD | -4,200,000USD | -6,000,000USD | -4,700,000USD |
| Free Cash Flow | -7,700,000USD | -26,800,000USD | 2,300,000USD | 1,400,000USD | 9,800,000USD | 5,300,000USD | 19,900,000USD | 3,300,000USD |
| Investments | 3,100,000USD | 4,000,000USD | 5,400,000USD | -700,000USD | 14,700,000USD | -3,000,000USD | -14,000,000USD | 7,700,000USD |
| Total Cashflows From Investing Activities | -3,100,000USD | -7,700,000USD | -700,000USD | -700,000USD | 14,700,000USD | -3,000,000USD | -14,000,000USD | 7,700,000USD |
| Net Borrowings | -23,200,000USD | 0USD | -400,000USD | -200,400,000USD | -400,000USD | 126,200,000USD | -400,000USD | — |
| Total Cash From Financing Activities | -29,300,000USD | -1,600,000USD | 1,100,000USD | -201,200,000USD | -700,000USD | 124,900,000USD | 800,000USD | -1,100,000USD |
| Sale Purchase Of Stock | 1,500,000USD | -1,500,000USD | — | — | — | -1,200,000USD | -300,000USD | -100,000USD |
| Change In Cash | -34,200,000USD | -25,400,000USD | 8,600,000USD | -193,700,000USD | 30,400,000USD | 131,400,000USD | 12,600,000USD | 14,600,000USD |
| Begin Period Cash Flow | 119,500,000USD | 147,100,000USD | 138,500,000USD | 332,200,000USD | 301,800,000USD | 170,400,000USD | 157,800,000USD | 143,200,000USD |
| End Period Cash Flow | 85,300,000USD | 121,700,000USD | 147,100,000USD | 138,500,000USD | 332,200,000USD | 301,800,000USD | 170,400,000USD | 157,800,000USD |
| Other Cashflows From Financing Activities | -7,800,000USD | -100,000USD | -100,000USD | -800,000USD | -300,000USD | -1,300,000USD | 1,500,000USD | -700,000USD |
| Unclassified Operating Cash Flow | -4,100,000USD | — | 2,700,000USD | -3,400,000USD | — | — | 51,400,000USD | -7,700,000USD |
| Other Cashflows From Investing Activities | — | -1,000,000USD | -500,000USD | 800,000USD | -200,000USD | -900,000USD | 300,000USD | -400,000USD |
| Unclassified Financing Cash Flow | — | — | 1,600,000USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | 5,500,000USD | 7,000,000USD | 5,100,000USD | 5,700,000USD | 5,100,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD | FY 20172017-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -69,900,000USD | -47,200,000USD | 30,800,000USD | 17,900,000USD | -57,400,000USD | 15,800,000USD | 28,300,000USD | 52,000,000USD |
| Depreciation | 27,200,000USD | 31,100,000USD | 33,600,000USD | 37,300,000USD | 39,500,000USD | 39,200,000USD | 42,200,000USD | 27,400,000USD |
| Stock Based Compensation | 15,000,000USD | 15,300,000USD | 14,000,000USD | 13,900,000USD | 13,400,000USD | 11,700,000USD | 10,000,000USD | 8,400,000USD |
| Other Non Cash Items | 101,300,000USD | 9,100,000USD | 25,900,000USD | 18,300,000USD | 34,700,000USD | 13,400,000USD | 6,500,000USD | 2,300,000USD |
| Change To Account Receivables | 100,000USD | 6,700,000USD | -18,100,000USD | -32,900,000USD | 17,700,000USD | 14,800,000USD | 9,000,000USD | -23,100,000USD |
| Change To Inventory | -39,900,000USD | 6,600,000USD | -85,000,000USD | 42,800,000USD | -42,700,000USD | -11,100,000USD | -2,400,000USD | -4,200,000USD |
| Change In Working Capital | -31,400,000USD | 2,000,000USD | -88,000,000USD | 8,200,000USD | -13,900,000USD | 4,700,000USD | 6,000,000USD | -6,600,000USD |
| Total Cash From Operating Activities | 41,700,000USD | 47,300,000USD | 16,900,000USD | 92,600,000USD | 13,200,000USD | 71,900,000USD | 85,300,000USD | 74,600,000USD |
| Capital Expenditures | -22,900,000USD | -26,900,000USD | -21,300,000USD | -15,100,000USD | -23,500,000USD | -19,800,000USD | -20,400,000USD | -20,200,000USD |
| Free Cash Flow | 18,800,000USD | 20,400,000USD | -4,400,000USD | 77,500,000USD | -10,300,000USD | 52,100,000USD | 64,900,000USD | 55,000,000USD |
| Investments | 10,300,000USD | -27,500,000USD | -26,900,000USD | -1,400,000USD | -26,900,000USD | -93,200,000USD | -25,800,000USD | -292,000,000USD |
| Total Cashflows From Investing Activities | 10,300,000USD | -27,500,000USD | -48,400,000USD | -16,200,000USD | -26,900,000USD | -93,200,000USD | -25,200,000USD | -292,000,000USD |
| Net Borrowings | -75,000,000USD | -1,600,000USD | -29,400,000USD | -31,600,000USD | 109,900,000USD | -1,600,000USD | -96,000,000USD | 494,000,000USD |
| Total Cash From Financing Activities | -75,900,000USD | -3,300,000USD | -23,800,000USD | -32,300,000USD | 83,600,000USD | -100,000USD | -90,400,000USD | 263,300,000USD |
| Change In Cash | -23,300,000USD | 16,400,000USD | -55,500,000USD | 44,000,000USD | 70,800,000USD | -22,100,000USD | -30,800,000USD | 47,400,000USD |
| Begin Period Cash Flow | 170,400,000USD | 154,000,000USD | 146,100,000USD | 102,100,000USD | 31,300,000USD | 53,400,000USD | 84,200,000USD | 36,800,000USD |
| End Period Cash Flow | 147,100,000USD | 170,400,000USD | 90,600,000USD | 146,100,000USD | 102,100,000USD | 31,300,000USD | 53,400,000USD | 84,200,000USD |
| Other Cashflows From Investing Activities | -800,000USD | -1,100,000USD | -1,900,000USD | 300,000USD | -3,400,000USD | -73,400,000USD | -600,000USD | -600,000USD |
| Other Cashflows From Financing Activities | -4,200,000USD | -1,700,000USD | 5,600,000USD | -700,000USD | -26,300,000USD | 1,500,000USD | 5,600,000USD | -494,000,000USD |
| Unclassified Investing Cash Flow | 23,700,000USD | 28,000,000USD | 1,700,000USD | — | 26,900,000USD | 93,200,000USD | 21,600,000USD | 20,800,000USD |
| Unclassified Financing Cash Flow | 3,300,000USD | 2,200,000USD | 5,600,000USD | 2,800,000USD | 54,900,000USD | 2,600,000USD | 2,900,000USD | 492,300,000USD |
| Sale Purchase Of Stock | — | -2,200,000USD | -2,800,000USD | -1,500,000USD | -1,800,000USD | -2,100,000USD | -2,300,000USD | -1,900,000USD |
| Unclassified Operating Cash Flow | — | 37,000,000USD | — | -3,000,000USD | -3,100,000USD | -12,900,000USD | -7,700,000USD | -8,900,000USD |
| Change To Liabilities | — | — | 19,700,000USD | -800,000USD | 12,300,000USD | -14,200,000USD | 7,600,000USD | 3,300,000USD |
| Dividends Paid | — | — | -2,800,000USD | -1,300,000USD | -53,100,000USD | -500,000USD | -600,000USD | -227,100,000USD |
| Cash And Cash Equivalents Changes | — | — | -55,300,000USD | 44,100,000USD | 69,900,000USD | -21,400,000USD | -31,400,000USD | 46,800,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | -500,000USD | 900,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-03-31 | Geography | Americas | 78,700,000 | USD | 0001681622-26-000052 |
| Q2 2026Quarterly · 2026-03-31 | Geography | Asia Pacific | 77,400,000 | USD | 0001681622-26-000052 |
| Q2 2026Quarterly · 2026-03-31 | Geography | EMEA | 59,900,000 | USD | 0001681622-26-000052 |
| Q2 2026Quarterly · 2026-03-31 | Segment | Industrial | 59,800,000 | USD | 0001681622-26-000052 |
| Q2 2026Quarterly · 2026-03-31 | Segment | Medical | 156,200,000 | USD | 0001681622-26-000052 |
| Q1 2026Quarterly · 2025-12-31 | Geography | Americas | 75,300,000 | USD | 0001681622-26-000016 |
| Q1 2026Quarterly · 2025-12-31 | Geography | Asia Pacific | 69,900,000 | USD | 0001681622-26-000016 |
| Q1 2026Quarterly · 2025-12-31 | Geography | EMEA | 64,400,000 | USD | 0001681622-26-000016 |
| Q1 2026Quarterly · 2025-12-31 | Segment | Industrial | 64,800,000 | USD | 0001681622-26-000016 |
| Q1 2026Quarterly · 2025-12-31 | Segment | Medical | 144,800,000 | USD | 0001681622-26-000016 |
| Q4 2025Quarterly · 2025-09-30 | Geography | Americas | 71,700,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-09-30 | Geography | Asia Pacific | 74,100,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-09-30 | Geography | EMEA | 83,100,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-09-30 | Segment | Industrial | 76,800,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-09-30 | Segment | Medical | 152,100,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-09-30 | Geography | Americas | 276,500,000 | USD | 0001681622-25-000108 |
| FY 2025Yearly · 2025-09-30 | Geography | Asia Pacific | 283,300,000 | USD | 0001681622-25-000108 |
| FY 2025Yearly · 2025-09-30 | Geography | EMEA | 284,800,000 | USD | 0001681622-25-000108 |
| FY 2025Yearly · 2025-09-30 | Segment | Industrial | 252,000,000 | USD | 0001681622-25-000108 |
| FY 2025Yearly · 2025-09-30 | Segment | Medical | 592,600,000 | USD | 0001681622-25-000108 |
| Q3 2025Quarterly · 2025-06-30 | Geography | Americas | 71,000,000 | USD | 0001681622-25-000084 |
| Q3 2025Quarterly · 2025-06-30 | Geography | Asia Pacific | 62,400,000 | USD | 0001681622-25-000084 |
| Q3 2025Quarterly · 2025-06-30 | Geography | EMEA | 69,600,000 | USD | 0001681622-25-000084 |
| Q3 2025Quarterly · 2025-06-30 | Segment | Industrial | 60,900,000 | USD | 0001681622-25-000084 |
| Q3 2025Quarterly · 2025-06-30 | Segment | Medical | 142,100,000 | USD | 0001681622-25-000084 |
| Q2 2025Quarterly · 2025-03-31 | Geography | Americas | 69,400,000 | USD | 0001681622-26-000052 |
| Q2 2025Quarterly · 2025-03-31 | Geography | Asia Pacific | 71,800,000 | USD | 0001681622-26-000052 |
| Q2 2025Quarterly · 2025-03-31 | Geography | EMEA | 71,700,000 | USD | 0001681622-26-000052 |
| Q2 2025Quarterly · 2025-03-31 | Segment | Industrial | 59,100,000 | USD | 0001681622-26-000052 |
| Q2 2025Quarterly · 2025-03-31 | Segment | Medical | 153,800,000 | USD | 0001681622-26-000052 |
| Q1 2025Quarterly · 2024-12-31 | Geography | Americas | 64,400,000 | USD | 0001681622-26-000016 |
| Q1 2025Quarterly · 2024-12-31 | Geography | Asia Pacific | 75,000,000 | USD | 0001681622-26-000016 |
| Q1 2025Quarterly · 2024-12-31 | Geography | EMEA | 60,400,000 | USD | 0001681622-26-000016 |
| Q1 2025Quarterly · 2024-12-31 | Segment | Industrial | 55,200,000 | USD | 0001681622-26-000016 |
| Q1 2025Quarterly · 2024-12-31 | Segment | Medical | 144,600,000 | USD | 0001681622-26-000016 |
| Q4 2024Quarterly · 2024-09-30 | Geography | Americas | 65,700,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Geography | Asia Pacific | 68,300,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Geography | EMEA | 71,700,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Segment | Industrial | 61,300,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Segment | Medical | 144,400,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-09-30 | Geography | Americas | 266,500,000 | USD | 0001681622-25-000108 |
| FY 2024Yearly · 2024-09-30 | Geography | Asia Pacific | 264,200,000 | USD | 0001681622-25-000108 |
| FY 2024Yearly · 2024-09-30 | Geography | EMEA | 280,300,000 | USD | 0001681622-25-000108 |
| FY 2024Yearly · 2024-09-30 | Segment | Industrial | 229,300,000 | USD | 0001681622-25-000108 |
| FY 2024Yearly · 2024-09-30 | Segment | Medical | 581,700,000 | USD | 0001681622-25-000108 |
| Q3 2024Quarterly · 2024-06-30 | Geography | Americas | 70,200,000 | USD | 0001681622-25-000084 |
| Q3 2024Quarterly · 2024-06-30 | Geography | Asia Pacific | 68,000,000 | USD | 0001681622-25-000084 |
| Q3 2024Quarterly · 2024-06-30 | Geography | EMEA | 70,900,000 | USD | 0001681622-25-000084 |
| Q3 2024Quarterly · 2024-06-30 | Segment | Industrial | 60,500,000 | USD | 0001681622-25-000084 |
| Q3 2024Quarterly · 2024-06-30 | Segment | Medical | 148,600,000 | USD | 0001681622-25-000084 |
| FY 2023Yearly · 2023-09-30 | Geography | Americas | 281,800,000 | USD | 0001681622-25-000108 |
| FY 2023Yearly · 2023-09-30 | Geography | Asia Pacific | 320,900,000 | USD | 0001681622-25-000108 |
| FY 2023Yearly · 2023-09-30 | Geography | EMEA | 290,700,000 | USD | 0001681622-25-000108 |
| FY 2023Yearly · 2023-09-30 | Segment | Industrial | 220,100,000 | USD | 0001681622-25-000108 |
| FY 2023Yearly · 2023-09-30 | Segment | Medical | 673,300,000 | USD | 0001681622-25-000108 |
| FY 2022Yearly · 2022-09-30 | Geography | Americas | 273,300,000 | USD | 0001681622-24-000089 |
| FY 2022Yearly · 2022-09-30 | Geography | Asia Pacific | 305,300,000 | USD | 0001681622-24-000089 |
| FY 2022Yearly · 2022-09-30 | Geography | EMEA | 280,800,000 | USD | 0001681622-24-000089 |
| FY 2022Yearly · 2022-09-30 | Segment | Industrial | 184,700,000 | USD | 0001681622-24-000089 |
| FY 2022Yearly · 2022-09-30 | Segment | Medical | 674,700,000 | USD | 0001681622-24-000089 |
| FY 2021Yearly · 2021-09-30 | Geography | Americas | 268,500,000 | USD | 0001681622-23-000074 |
| FY 2021Yearly · 2021-09-30 | Geography | Asia Pacific | 273,300,000 | USD | 0001681622-23-000074 |
| FY 2021Yearly · 2021-09-30 | Geography | EMEA | 276,300,000 | USD | 0001681622-23-000074 |
| FY 2021Yearly · 2021-09-30 | Segment | Industrial | 174,300,000 | USD | 0001681622-23-000074 |
| FY 2021Yearly · 2021-09-30 | Segment | Medical | 643,800,000 | USD | 0001681622-23-000074 |
| FY 2020Yearly · 2020-09-30 | Geography | Asia Pacific | 251,800,000 | USD | 0001681622-20-000116 |
| FY 2020Yearly · 2020-09-30 | Geography | EMEA | 231,500,000 | USD | 0001681622-20-000116 |
| FY 2020Yearly · 2020-09-30 | Geography | Latin America | 5,200,000 | USD | 0001681622-20-000116 |
| FY 2020Yearly · 2020-09-30 | Geography | United States | 249,800,000 | USD | 0001681622-20-000116 |
| FY 2020Yearly · 2020-09-30 | Segment | Industrial | 153,800,000 | USD | 0001681622-22-000091 |
| FY 2020Yearly · 2020-09-30 | Segment | Medical | 584,500,000 | USD | 0001681622-22-000091 |
| FY 2019Yearly · 2019-09-30 | Geography | Asia Pacific | 229,000,000 | USD | 0001681622-20-000116 |
| FY 2019Yearly · 2019-09-30 | Geography | EMEA | 269,000,000 | USD | 0001681622-20-000116 |
| FY 2019Yearly · 2019-09-30 | Geography | Latin America | 7,300,000 | USD | 0001681622-20-000116 |
| FY 2019Yearly · 2019-09-30 | Geography | United States | 275,300,000 | USD | 0001681622-20-000116 |
| FY 2019Yearly · 2019-09-30 | Segment | Industrial | 183,800,000 | USD | 0001681622-21-000103 |
| FY 2019Yearly · 2019-09-30 | Segment | Medical | 596,800,000 | USD | 0001681622-21-000103 |
| FY 2018Yearly · 2018-09-30 | Geography | Asia Pacific | 243,100,000 | USD | 0001681622-20-000116 |
| FY 2018Yearly · 2018-09-30 | Geography | EMEA | 254,500,000 | USD | 0001681622-20-000116 |
| FY 2018Yearly · 2018-09-30 | Geography | Latin America | 7,000,000 | USD | 0001681622-20-000116 |
| FY 2018Yearly · 2018-09-30 | Geography | United States | 268,800,000 | USD | 0001681622-20-000116 |
| FY 2018Yearly · 2018-09-30 | Segment | Industrial | 171,400,000 | USD | 0001681622-20-000116 |
| FY 2018Yearly · 2018-09-30 | Segment | Medical | 602,000,000 | USD | 0001681622-20-000116 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.